What is the appropriate evaluation and management for a patient presenting with a new scrotal bump?

Evaluation and Management of a New Scrotal Bump

For a patient presenting with a new scrotal bump without acute pain or trauma, obtain a scrotal ultrasound with Doppler as the initial and definitive imaging study to differentiate between benign and malignant lesions, as any solid intratesticular mass must be managed as malignant until proven otherwise. 1, 2

Initial Clinical Assessment

Focus your history and physical examination on these specific elements:

• Timing and onset: Gradual appearance suggests benign processes (hydrocele, varicocele, epididymal cyst) or malignancy; acute onset with pain raises concern for torsion or infection
• Pain characteristics: Painless masses are more concerning for malignancy (though 15% of testicular cancers present with pain) 3
• Location specificity: Determine if the mass is intratesticular versus extratesticular on palpation—intratesticular masses are malignant until proven otherwise 1
• Associated symptoms: Fever, dysuria, or urethral discharge suggest infectious etiology

Imaging Protocol

Scrotal ultrasound with Doppler is the only appropriate initial imaging modality 1, 2:

• Achieves 98-100% accuracy in distinguishing intratesticular from extratesticular processes 2
• Nearly 100% sensitive for detecting intrascrotal masses 2
• Provides no radiation exposure
• Do not use MRI, CT, or nuclear medicine as initial imaging—these add no diagnostic value and delay appropriate management 1, 2

Ultrasound Interpretation

The ultrasound findings dictate your next steps:

• Solid or mixed intratesticular mass: Proceed immediately to urologic consultation for tumor markers and surgical planning
• Hypoechoic or inhomogeneous intratesticular lesion: Treat as suspicious for malignancy 2
• Extratesticular mass: Usually benign (epididymal cyst, spermatocele, hydrocele, varicocele)—can be managed non-urgently
• Indeterminate findings with normal tumor markers: Repeat ultrasound in 6-8 weeks 1

Laboratory Workup for Suspected Malignancy

Before any surgical intervention, obtain serum tumor markers 1:

• Alpha-fetoprotein (AFP)
• Human chorionic gonadotropin (hCG)
• Lactate dehydrogenase (LDH)

These markers are essential for staging, prognosis, and monitoring—draw them before orchiectomy as the opportunity is lost once the testicle is removed 1.

Management Algorithm Based on Ultrasound Findings

If Intratesticular Solid Mass Identified:

1. Urgent urology referral (same day to within 48 hours)
2. Counsel regarding fertility preservation—offer sperm banking before any intervention 1
3. Discuss risks of hypogonadism if bilateral disease or solitary testicle 1
4. Proceed to radical inguinal orchiectomy (not trans-scrotal approach)
5. Consider testis-sparing surgery only for bilateral disease, solitary testis, or masses <2 cm with intraoperative frozen section 1

If Extratesticular Mass or Benign-Appearing Lesion:

• Hydrocele, varicocele, spermatocele: Non-urgent urology referral if symptomatic or patient desires treatment
• Epididymal cyst: Reassurance, no intervention needed unless symptomatic
• Inguinal hernia: Surgical referral for elective repair

If Indeterminate Findings:

• Repeat ultrasound in 6-8 weeks if tumor markers normal 1
• If mass persists or grows, proceed to urologic evaluation
• Do not observe solid intratesticular masses—these require definitive diagnosis

Critical Pitfalls to Avoid

Do not biopsy scrotal masses trans-scrotally—this violates oncologic principles and can seed the scrotum with tumor cells. The correct approach for suspected testicular cancer is radical inguinal orchiectomy with high ligation of the spermatic cord 1.

Do not dismiss testicular microlithiasis alone as requiring intervention—in the absence of a solid mass or risk factors (cryptorchidism, family history, personal history of germ cell tumor), microlithiasis does not increase cancer risk and needs no follow-up 1.

Do not delay imaging for "clinical observation" of a palpable testicular mass—up to 50-80% of non-palpable masses <2 cm may be benign 1, but any palpable solid intratesticular mass warrants immediate ultrasound evaluation.

Special Considerations

The evidence shows that while clinical examination has high sensitivity for detecting abnormalities 4, 5, ultrasound is mandatory for any palpable scrotal mass because clinical examination alone cannot reliably differentiate benign from malignant intratesticular lesions 2. The 2024 ACR guidelines and 2019 AUA guidelines are consistent in recommending ultrasound as the definitive initial study 6, 1, 6, 2.

For patients with normal physical examination but concerning symptoms, ultrasound may identify clinically occult lesions, though routine screening in asymptomatic patients is not indicated 4, 5.